v3.25.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity and Weighted Average Exercise Prices
The following table is a summary of the Company’s stock option activity and weighted average exercise prices for the three months ended March 31, 2025:
Stock Option ActivityWeighted Average Remaining Contractual Term
(In years)		Aggregate Intrinsic Value
(In thousands)
Options
(In thousands)		Weighted
Average
Exercise Price
Balance outstanding at December 31, 20242,663 $22.93 3.95$7 
Granted— — 
Exercised— — 
Cancelled or expired(46)19.08 
Balance outstanding at March 31, 20252,617 14.95 5.662 
Options vested and expected to vest 701 4.33 8.74— 
Options exercisable at March 31, 20251,532 $23.07 3.45$2 
The total fair value of stock options exercised during the three months ended March 31, 2025 and 2024 was immaterial.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table is a summary of the Company’s RSU and PRSU activity and weighted average grant date fair value for the three months ended March 31, 2025:
Number of Shares
Weighted Average Grant Date Fair Value
Aggregate Fair Value
(In thousands)(Per share)(In thousands)
Balance outstanding at December 31, 202412,522 $2.03 
Awarded618 1.25 
Vested(2,221)1.76 
Forfeited(116)9.81 
Non-vested and outstanding at March 31, 202510,803 1.86 8,632 
Expected to vest 8,520 $2.00 $6,808 
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award
Total stock-based compensation costs included in the condensed consolidated statements of operations for the three months ended March 31, 2025 and 2024 are as follows:
Three Months Ended March 31,
20252024
(In thousands)
Cost of revenue $186 $343 
Sales and marketing 1,378 2,455 
General and administrative 1,773 1,798 
Product development 1,372 2,962 
Total$4,709 $7,558